TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE
- 23 January 1960
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 275 (7117), 188-192
- https://doi.org/10.1016/s0140-6736(60)90109-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- THE ACTION OF CHELATING AGENTS IN WILSON'S DISEASEThe Lancet, 1959
- Current Views on the Pathogenesis and Treatment of Wilson's DiseaseArchives of Internal Medicine, 1959
- THE DIAGNOSIS AND TREATMENT OF WILSON'S DISEASEBrain, 1958
- EFFECTS OF PENICILLAMINE AND DIMERCAPROL ON TURNOVER OF COPPER IN PATIENTS WITH WILSON'S DISEASEThe Lancet, 1958
- An increased vitamin B6 requirement in the rat on a diet containing l-penicillamineArchives of Biochemistry and Biophysics, 1957
- Penicillamine, a new oral therapy for Wilson's diseaseAmerican Journal Of Medicine, 1956
- Studies on Copper Metabolism. XIII. Hepatolenticular Degeneration1JCI Insight, 1954
- The Effect of BAL (2,3-Dimercaptopropanol) on Hepatolenticular Degeneration (Wilson's Disease)New England Journal of Medicine, 1951
- THE EFFECTS OF B.A.L. IN HEPATOLENTICULAR DEGENERATIONBrain, 1951
- THE COPPER AND IRON CONTENT OF BRAIN AND LIVER IN THE NORMAL AND IN HEPATO-LENTICULAR DEGENERATIONBrain, 1948